

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | interferon-gamma production (GO:0032609) | 8.35118363 |
| 2 | negative T cell selection (GO:0043383) | 7.76935432 |
| 3 | negative thymic T cell selection (GO:0045060) | 7.46388899 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.21133719 |
| 5 | T cell migration (GO:0072678) | 7.15790083 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.76811691 |
| 7 | negative regulation of cell killing (GO:0031342) | 6.72654010 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.72654010 |
| 9 | regulation of natural killer cell mediated immunity (GO:0002715) | 6.52402782 |
| 10 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 6.52402782 |
| 11 | positive T cell selection (GO:0043368) | 6.42373828 |
| 12 | thymic T cell selection (GO:0045061) | 6.31900426 |
| 13 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.28517198 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.27858117 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 6.13494553 |
| 16 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.01595607 |
| 17 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.01595607 |
| 18 | leukocyte aggregation (GO:0070486) | 5.79339001 |
| 19 | response to interleukin-15 (GO:0070672) | 5.71912939 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.63055369 |
| 21 | activated T cell proliferation (GO:0050798) | 5.58036004 |
| 22 | T cell selection (GO:0045058) | 5.32582336 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.32379858 |
| 24 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.26661066 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.22129591 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.22129591 |
| 27 | DNA deamination (GO:0045006) | 5.15198086 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 5.03536382 |
| 29 | T cell receptor signaling pathway (GO:0050852) | 5.01939911 |
| 30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.94688714 |
| 31 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.93590764 |
| 32 | cellular defense response (GO:0006968) | 4.91810700 |
| 33 | sequestering of actin monomers (GO:0042989) | 4.89664838 |
| 34 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.85914429 |
| 35 | T cell costimulation (GO:0031295) | 4.85118216 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.83473108 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 4.81313556 |
| 38 | lymphocyte costimulation (GO:0031294) | 4.75767941 |
| 39 | cytidine deamination (GO:0009972) | 4.75416544 |
| 40 | cytidine metabolic process (GO:0046087) | 4.75416544 |
| 41 | cytidine catabolic process (GO:0006216) | 4.75416544 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75059752 |
| 43 | lymphocyte migration (GO:0072676) | 4.68038729 |
| 44 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.56586448 |
| 45 | positive regulation of B cell mediated immunity (GO:0002714) | 4.56586448 |
| 46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.53074182 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 4.52827371 |
| 48 | positive regulation of immune response to tumor cell (GO:0002839) | 4.50185491 |
| 49 | regulation of immune response to tumor cell (GO:0002837) | 4.50185491 |
| 50 | regulation of response to tumor cell (GO:0002834) | 4.50185491 |
| 51 | positive regulation of response to tumor cell (GO:0002836) | 4.50185491 |
| 52 | positive regulation of cell killing (GO:0031343) | 4.50021105 |
| 53 | regulation of cell killing (GO:0031341) | 4.49818610 |
| 54 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.45784271 |
| 55 | positive regulation of isotype switching (GO:0045830) | 4.43066528 |
| 56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.35352859 |
| 57 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.28845211 |
| 58 | natural killer cell activation (GO:0030101) | 4.20283925 |
| 59 | regulation of T cell chemotaxis (GO:0010819) | 4.19910881 |
| 60 | positive regulation of T cell chemotaxis (GO:0010820) | 4.19910881 |
| 61 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.19070340 |
| 62 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.07419185 |
| 63 | regulation of B cell mediated immunity (GO:0002712) | 4.02784909 |
| 64 | mast cell activation (GO:0045576) | 4.00362634 |
| 65 | positive regulation of DNA recombination (GO:0045911) | 3.95060794 |
| 66 | positive regulation of tolerance induction (GO:0002645) | 3.91860931 |
| 67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.90212733 |
| 68 | leukocyte cell-cell adhesion (GO:0007159) | 3.89734464 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72030648 |
| 70 | regulation of isotype switching (GO:0045191) | 3.71735869 |
| 71 | heterotypic cell-cell adhesion (GO:0034113) | 3.70844923 |
| 72 | regulation of B cell differentiation (GO:0045577) | 3.70384658 |
| 73 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.64259599 |
| 74 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.57987306 |
| 75 | regulation of regulatory T cell differentiation (GO:0045589) | 3.56474957 |
| 76 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.54886929 |
| 77 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.53388222 |
| 78 | regulation of response to interferon-gamma (GO:0060330) | 3.52799983 |
| 79 | regulation of tolerance induction (GO:0002643) | 3.52550575 |
| 80 | negative regulation of type 2 immune response (GO:0002829) | 3.48119203 |
| 81 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.47940483 |
| 82 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.46696016 |
| 83 | positive regulation of lamellipodium assembly (GO:0010592) | 3.46415445 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 3.46058596 |
| 85 | positive regulation of defense response to virus by host (GO:0002230) | 3.45269076 |
| 86 | indole-containing compound catabolic process (GO:0042436) | 3.43985952 |
| 87 | indolalkylamine catabolic process (GO:0046218) | 3.43985952 |
| 88 | tryptophan catabolic process (GO:0006569) | 3.43985952 |
| 89 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.43985328 |
| 90 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.43692101 |
| 91 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41872142 |
| 92 | T cell differentiation (GO:0030217) | 3.39968399 |
| 93 | positive regulation of immunoglobulin production (GO:0002639) | 3.36427885 |
| 94 | T cell activation (GO:0042110) | 3.36275984 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.36086782 |
| 96 | positive regulation of humoral immune response (GO:0002922) | 3.33465391 |
| 97 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.33006004 |
| 98 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.32305473 |
| 99 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.32122085 |
| 100 | cellular extravasation (GO:0045123) | 3.27697147 |
| 101 | regulation of hypersensitivity (GO:0002883) | 3.24133876 |
| 102 | adaptation of signaling pathway (GO:0023058) | 3.21048947 |
| 103 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.19974036 |
| 104 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.19074451 |
| 105 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.18330015 |
| 106 | lymphocyte chemotaxis (GO:0048247) | 3.17687598 |
| 107 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.14876878 |
| 108 | cytolysis (GO:0019835) | 3.12775570 |
| 109 | positive regulation of interferon-gamma production (GO:0032729) | 3.11873839 |
| 110 | positive regulation of interleukin-2 production (GO:0032743) | 3.10248012 |
| 111 | T cell homeostasis (GO:0043029) | 3.09363443 |
| 112 | kynurenine metabolic process (GO:0070189) | 3.08170248 |
| 113 | sulfation (GO:0051923) | 3.07658626 |
| 114 | regulation of immunoglobulin production (GO:0002637) | 3.06306182 |
| 115 | response to type I interferon (GO:0034340) | 3.05330045 |
| 116 | tryptophan metabolic process (GO:0006568) | 3.00787582 |
| 117 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.97919826 |
| 118 | neural tube formation (GO:0001841) | 2.96371833 |
| 119 | negative regulation of mast cell activation (GO:0033004) | 2.94673532 |
| 120 | signal peptide processing (GO:0006465) | 2.91118924 |
| 121 | behavioral response to nicotine (GO:0035095) | 2.83874642 |
| 122 | regulation of activation of Janus kinase activity (GO:0010533) | 2.83378430 |
| 123 | L-fucose catabolic process (GO:0042355) | 2.82978874 |
| 124 | fucose catabolic process (GO:0019317) | 2.82978874 |
| 125 | L-fucose metabolic process (GO:0042354) | 2.82978874 |
| 126 | negative regulation of B cell proliferation (GO:0030889) | 2.82396153 |
| 127 | regulation of memory T cell differentiation (GO:0043380) | 2.79400970 |
| 128 | establishment of protein localization to Golgi (GO:0072600) | 2.78603809 |
| 129 | positive regulation of granulocyte differentiation (GO:0030854) | 2.77712335 |
| 130 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.77003028 |
| 131 | microglial cell activation (GO:0001774) | 2.63386651 |
| 132 | negative regulation by host of viral transcription (GO:0043922) | 2.63289242 |
| 133 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.63024605 |
| 134 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.59989024 |
| 135 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.59311720 |
| 136 | protein K48-linked deubiquitination (GO:0071108) | 2.58769015 |
| 137 | cellular response to ethanol (GO:0071361) | 2.56611602 |
| 138 | detection of light stimulus involved in visual perception (GO:0050908) | 2.56158202 |
| 139 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.56158202 |
| 140 | regulation of gene silencing by RNA (GO:0060966) | 2.53070220 |
| 141 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.53070220 |
| 142 | regulation of gene silencing by miRNA (GO:0060964) | 2.53070220 |
| 143 | positive regulation of B cell differentiation (GO:0045579) | 2.50743186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.23317569 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.44602507 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.92400519 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.30035358 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.15343548 |
| 6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.95957923 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.92192517 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.72208445 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.35756528 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31906191 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 3.10399793 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.09883765 |
| 13 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.05907568 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00800538 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.92930268 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.89910132 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.81171029 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.73503230 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.51038156 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.48384853 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.43390310 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 2.38691367 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33832676 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.29427908 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.24876572 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21668464 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18715936 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.18025521 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13564854 |
| 30 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.12210352 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12063848 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.10331594 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06549700 |
| 34 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01999125 |
| 35 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.98793581 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97804271 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.92859322 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91848726 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87151955 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86374789 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85906422 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85133576 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81445665 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79818618 |
| 45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.78341078 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.77283825 |
| 47 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.74848345 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.70284772 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67564900 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66734738 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66212005 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65942933 |
| 53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64148975 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62783503 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62665694 |
| 56 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60402791 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.52880785 |
| 58 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52293232 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48884422 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47615125 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46968474 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45126401 |
| 63 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45056291 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44959146 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44613270 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44464844 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44243766 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.43257257 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43129722 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42265519 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41962919 |
| 72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41136868 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40311439 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39732466 |
| 75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.38225076 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37848057 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37372702 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.37032704 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35271104 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.34407193 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33349168 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.32454335 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32452861 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.31733735 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31005735 |
| 86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30683553 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30519295 |
| 88 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30000294 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29287804 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28834204 |
| 91 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26325199 |
| 92 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.26264027 |
| 93 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25061691 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24175774 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24175774 |
| 96 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.23836653 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23733086 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23655663 |
| 99 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21846310 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19626147 |
| 101 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19626147 |
| 102 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19011143 |
| 103 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17532879 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16855098 |
| 105 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15279850 |
| 106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14850069 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13450889 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.13399033 |
| 109 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13193698 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12877328 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10490242 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09874826 |
| 113 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.09403200 |
| 114 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.09403200 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08457334 |
| 116 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07904331 |
| 117 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07718534 |
| 118 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.07260979 |
| 119 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07214926 |
| 120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06919869 |
| 121 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06349799 |
| 122 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06349799 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06168143 |
| 124 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06033367 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06003685 |
| 126 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05985696 |
| 127 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05628189 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05538859 |
| 129 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04805464 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04110791 |
| 131 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04045218 |
| 132 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04021431 |
| 133 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03942151 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03354513 |
| 135 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02705694 |
| 136 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02675052 |
| 137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01563513 |
| 138 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01430499 |
| 139 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01177898 |
| 140 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00990757 |
| 141 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00171154 |
| 142 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00058670 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.98760268 |
| 144 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98142278 |
| 145 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97484146 |
| 146 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97456964 |
| 147 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97419218 |
| 148 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.97248370 |
| 149 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96994160 |
| 150 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93743855 |
| 151 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93250242 |
| 152 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90883078 |
| 153 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88853277 |
| 154 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87975841 |
| 155 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87910319 |
| 156 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.85539623 |
| 157 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.82802453 |
| 158 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82628627 |
| 159 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80840551 |
| 160 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80394738 |
| 161 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.80083365 |
| 162 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.78833373 |
| 163 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78502769 |
| 164 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77838730 |
| 165 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76722769 |
| 166 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74857235 |
| 167 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73498741 |
| 168 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71613641 |
| 169 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70178471 |
| 170 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.67899391 |
| 171 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.67709005 |
| 172 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.63396854 |
| 173 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.63100088 |
| 174 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63029392 |
| 175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62879770 |
| 176 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62393122 |
| 177 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.61729467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.75768553 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.54669835 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.99138023 |
| 4 | MP0009785_altered_susceptibility_to | 3.71899417 |
| 5 | MP0006082_CNS_inflammation | 3.49875604 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.47743310 |
| 7 | MP0000685_abnormal_immune_system | 3.38203306 |
| 8 | MP0001800_abnormal_humoral_immune | 3.28812619 |
| 9 | MP0002420_abnormal_adaptive_immunity | 3.14915088 |
| 10 | MP0001819_abnormal_immune_cell | 3.13521492 |
| 11 | MP0005025_abnormal_response_to | 3.06771546 |
| 12 | MP0002723_abnormal_immune_serum | 2.99147200 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.98006303 |
| 14 | MP0001790_abnormal_immune_system | 2.97866705 |
| 15 | MP0005387_immune_system_phenotype | 2.97866705 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.84030456 |
| 17 | MP0002398_abnormal_bone_marrow | 2.82932111 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.72798724 |
| 19 | MP0002006_tumorigenesis | 2.62744751 |
| 20 | MP0000716_abnormal_immune_system | 2.52092955 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.50604556 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.40871568 |
| 23 | MP0002722_abnormal_immune_system | 2.34198924 |
| 24 | MP0002405_respiratory_system_inflammati | 2.32098312 |
| 25 | MP0003195_calcinosis | 2.28440506 |
| 26 | MP0000858_altered_metastatic_potential | 2.27206685 |
| 27 | MP0003448_altered_tumor_morphology | 2.26711475 |
| 28 | MP0003436_decreased_susceptibility_to | 2.24860365 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.20743933 |
| 30 | MP0003646_muscle_fatigue | 2.20306123 |
| 31 | MP0003724_increased_susceptibility_to | 2.15283508 |
| 32 | MP0000689_abnormal_spleen_morphology | 2.14757811 |
| 33 | MP0001873_stomach_inflammation | 2.13965781 |
| 34 | MP0002419_abnormal_innate_immunity | 2.10414931 |
| 35 | MP0004947_skin_inflammation | 2.10039939 |
| 36 | MP0002429_abnormal_blood_cell | 2.01088296 |
| 37 | MP0002009_preneoplasia | 1.94960161 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.93821875 |
| 39 | MP0003866_abnormal_defecation | 1.89452286 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.88996348 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.85462424 |
| 42 | MP0002933_joint_inflammation | 1.79477528 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.78340932 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.72736539 |
| 45 | MP0004381_abnormal_hair_follicle | 1.65228233 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.63602334 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.58577751 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.56186450 |
| 49 | MP0002132_abnormal_respiratory_system | 1.54918653 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.52773438 |
| 51 | MP0003045_fibrosis | 1.48224397 |
| 52 | MP0004510_myositis | 1.45117133 |
| 53 | MP0004130_abnormal_muscle_cell | 1.43437978 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.41880442 |
| 55 | MP0006054_spinal_hemorrhage | 1.36936973 |
| 56 | MP0004043_abnormal_pH_regulation | 1.36649638 |
| 57 | MP0004142_abnormal_muscle_tone | 1.34898859 |
| 58 | MP0008469_abnormal_protein_level | 1.33989424 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.33651028 |
| 60 | MP0001853_heart_inflammation | 1.33067249 |
| 61 | MP0003787_abnormal_imprinting | 1.32601439 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.31140763 |
| 63 | MP0008872_abnormal_physiological_respon | 1.29614013 |
| 64 | MP0002163_abnormal_gland_morphology | 1.28814322 |
| 65 | MP0000427_abnormal_hair_cycle | 1.24522946 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.17948142 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.14550614 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.14389930 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.13063306 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.12450034 |
| 71 | MP0001851_eye_inflammation | 1.11682658 |
| 72 | MP0000490_abnormal_crypts_of | 1.10701970 |
| 73 | MP0009745_abnormal_behavioral_response | 1.09056830 |
| 74 | MP0005310_abnormal_salivary_gland | 1.06688674 |
| 75 | MP0003252_abnormal_bile_duct | 1.04723920 |
| 76 | MP0003303_peritoneal_inflammation | 1.00720656 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 1.00376589 |
| 78 | MP0002102_abnormal_ear_morphology | 0.99828072 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.95212858 |
| 80 | MP0001485_abnormal_pinna_reflex | 0.94374693 |
| 81 | MP0001533_abnormal_skeleton_physiology | 0.93617382 |
| 82 | MP0005174_abnormal_tail_pigmentation | 0.92145351 |
| 83 | MP0009046_muscle_twitch | 0.91308959 |
| 84 | MP0005253_abnormal_eye_physiology | 0.88750710 |
| 85 | MP0001919_abnormal_reproductive_system | 0.88538779 |
| 86 | MP0009763_increased_sensitivity_to | 0.88240674 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.87251578 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.86706670 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.86156376 |
| 90 | MP0003690_abnormal_glial_cell | 0.84843809 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.84187732 |
| 92 | MP0005646_abnormal_pituitary_gland | 0.83171354 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.81004324 |
| 94 | MP0003878_abnormal_ear_physiology | 0.81004324 |
| 95 | MP0002736_abnormal_nociception_after | 0.80056581 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 0.79682947 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.79525933 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.78671668 |
| 99 | MP0005389_reproductive_system_phenotype | 0.78671079 |
| 100 | MP0004742_abnormal_vestibular_system | 0.76992487 |
| 101 | MP0000604_amyloidosis | 0.76742801 |
| 102 | MP0005085_abnormal_gallbladder_physiolo | 0.76191770 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.75442408 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.74534491 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.74465761 |
| 106 | MP0002168_other_aberrant_phenotype | 0.73832681 |
| 107 | MP0000371_diluted_coat_color | 0.72608415 |
| 108 | MP0010307_abnormal_tumor_latency | 0.71875449 |
| 109 | MP0004883_abnormal_blood_vessel | 0.71458690 |
| 110 | MP0000470_abnormal_stomach_morphology | 0.71091977 |
| 111 | MP0009764_decreased_sensitivity_to | 0.70438048 |
| 112 | MP0000343_altered_response_to | 0.70090456 |
| 113 | MP0001243_abnormal_dermal_layer | 0.69737334 |
| 114 | MP0003329_amyloid_beta_deposits | 0.68193484 |
| 115 | MP0003136_yellow_coat_color | 0.68031793 |
| 116 | MP0005410_abnormal_fertilization | 0.67915245 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.65535785 |
| 118 | MP0002272_abnormal_nervous_system | 0.65431438 |
| 119 | MP0008873_increased_physiological_sensi | 0.64100558 |
| 120 | MP0005166_decreased_susceptibility_to | 0.64063894 |
| 121 | MP0005023_abnormal_wound_healing | 0.61740843 |
| 122 | MP0008057_abnormal_DNA_replication | 0.60226684 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.58160728 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.58156866 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.53211844 |
| 126 | MP0002095_abnormal_skin_pigmentation | 0.52957616 |
| 127 | MP0003795_abnormal_bone_structure | 0.51072720 |
| 128 | MP0000249_abnormal_blood_vessel | 0.49585179 |
| 129 | MP0000609_abnormal_liver_physiology | 0.48836134 |
| 130 | MP0000377_abnormal_hair_follicle | 0.48343230 |
| 131 | MP0004957_abnormal_blastocyst_morpholog | 0.47318026 |
| 132 | MP0001191_abnormal_skin_condition | 0.46746467 |
| 133 | MP0000477_abnormal_intestine_morphology | 0.45799366 |
| 134 | MP0000367_abnormal_coat/_hair | 0.45555454 |
| 135 | MP0003172_abnormal_lysosome_physiology | 0.42781381 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.42668121 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.42351528 |
| 138 | MP0000920_abnormal_myelination | 0.41365453 |
| 139 | MP0001881_abnormal_mammary_gland | 0.41361774 |
| 140 | MP0003950_abnormal_plasma_membrane | 0.40453543 |
| 141 | MP0008961_abnormal_basal_metabolism | 0.39925459 |
| 142 | MP0005408_hypopigmentation | 0.39441452 |
| 143 | MP0003077_abnormal_cell_cycle | 0.38726398 |
| 144 | MP0005451_abnormal_body_composition | 0.37364723 |
| 145 | MP0002083_premature_death | 0.35959316 |
| 146 | MP0002928_abnormal_bile_duct | 0.34395021 |
| 147 | MP0000627_abnormal_mammary_gland | 0.34174843 |
| 148 | MP0002693_abnormal_pancreas_physiology | 0.33914912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.73718293 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.42812867 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.30946382 |
| 4 | Myositis (HP:0100614) | 5.85332406 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.51762903 |
| 6 | Optic neuritis (HP:0100653) | 5.51762903 |
| 7 | Orchitis (HP:0100796) | 4.93349870 |
| 8 | Nasal polyposis (HP:0100582) | 4.86709805 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.85150253 |
| 10 | Abnormality of T cells (HP:0002843) | 4.79317172 |
| 11 | Encephalitis (HP:0002383) | 4.67406430 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 4.64123575 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.64097690 |
| 14 | Combined immunodeficiency (HP:0005387) | 4.55542617 |
| 15 | Recurrent abscess formation (HP:0002722) | 4.38177349 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.33128157 |
| 17 | Recurrent viral infections (HP:0004429) | 4.17896403 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.14470119 |
| 19 | Meningitis (HP:0001287) | 4.10957577 |
| 20 | Stomatitis (HP:0010280) | 4.07016503 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.04923652 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 4.04923652 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 4.03661660 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.97174008 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.95584755 |
| 26 | Pancreatic cysts (HP:0001737) | 3.74323921 |
| 27 | Chronic otitis media (HP:0000389) | 3.74083156 |
| 28 | IgM deficiency (HP:0002850) | 3.68346082 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 3.66194164 |
| 30 | IgG deficiency (HP:0004315) | 3.65768000 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.64918705 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.64296040 |
| 33 | Recurrent bronchitis (HP:0002837) | 3.58026181 |
| 34 | Genetic anticipation (HP:0003743) | 3.45235761 |
| 35 | Joint swelling (HP:0001386) | 3.45055933 |
| 36 | Increased IgM level (HP:0003496) | 3.39936268 |
| 37 | Gaze-evoked nystagmus (HP:0000640) | 3.34087698 |
| 38 | Recurrent skin infections (HP:0001581) | 3.29168842 |
| 39 | Congenital stationary night blindness (HP:0007642) | 3.24032491 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 3.20108547 |
| 41 | Hemoptysis (HP:0002105) | 3.13387182 |
| 42 | Pulmonary infiltrates (HP:0002113) | 3.13198059 |
| 43 | Leukocytosis (HP:0001974) | 3.07558256 |
| 44 | Arterial thrombosis (HP:0004420) | 3.06582686 |
| 45 | Agammaglobulinemia (HP:0004432) | 3.04830316 |
| 46 | Attenuation of retinal blood vessels (HP:0007843) | 3.04102206 |
| 47 | Lymphopenia (HP:0001888) | 3.03013210 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 3.01059453 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.97750739 |
| 50 | Vasculitis (HP:0002633) | 2.96537826 |
| 51 | Stomach cancer (HP:0012126) | 2.88718696 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.88165579 |
| 53 | Abnormality of eosinophils (HP:0001879) | 2.87393085 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.86084072 |
| 55 | Obstructive lung disease (HP:0006536) | 2.86084072 |
| 56 | Pancreatic fibrosis (HP:0100732) | 2.83551501 |
| 57 | Hypoproteinemia (HP:0003075) | 2.83139041 |
| 58 | Progressive cerebellar ataxia (HP:0002073) | 2.82622035 |
| 59 | Abnormality of the renal cortex (HP:0011035) | 2.80128641 |
| 60 | Pustule (HP:0200039) | 2.80000410 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.78338302 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.78119430 |
| 63 | Clumsiness (HP:0002312) | 2.76694839 |
| 64 | True hermaphroditism (HP:0010459) | 2.76624101 |
| 65 | Abolished electroretinogram (ERG) (HP:0000550) | 2.67050291 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.66843022 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.66611825 |
| 68 | Thyroiditis (HP:0100646) | 2.65899085 |
| 69 | Increased IgE level (HP:0003212) | 2.64805169 |
| 70 | Molar tooth sign on MRI (HP:0002419) | 2.61820723 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.61820723 |
| 72 | Pulmonary embolism (HP:0002204) | 2.61556412 |
| 73 | Eosinophilia (HP:0001880) | 2.57578867 |
| 74 | Hyperventilation (HP:0002883) | 2.56039718 |
| 75 | Spontaneous hematomas (HP:0007420) | 2.55449665 |
| 76 | Spondylolisthesis (HP:0003302) | 2.52987190 |
| 77 | Thrombocytosis (HP:0001894) | 2.52941730 |
| 78 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.51010416 |
| 79 | Spinal cord lesions (HP:0100561) | 2.46003407 |
| 80 | Syringomyelia (HP:0003396) | 2.46003407 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45748858 |
| 82 | Gangrene (HP:0100758) | 2.43814186 |
| 83 | Abnormality of the prostate (HP:0008775) | 2.43178966 |
| 84 | Metaphyseal dysplasia (HP:0100255) | 2.42878406 |
| 85 | Chronic diarrhea (HP:0002028) | 2.41228434 |
| 86 | Chest pain (HP:0100749) | 2.39219332 |
| 87 | Absent frontal sinuses (HP:0002688) | 2.39056455 |
| 88 | Abnormality of the fingertips (HP:0001211) | 2.31795273 |
| 89 | Type II lissencephaly (HP:0007260) | 2.29125677 |
| 90 | Abnormality of binocular vision (HP:0011514) | 2.27778742 |
| 91 | Diplopia (HP:0000651) | 2.27778742 |
| 92 | Colitis (HP:0002583) | 2.26270414 |
| 93 | Lymphoma (HP:0002665) | 2.26257118 |
| 94 | Granulocytopenia (HP:0001913) | 2.24994083 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24766663 |
| 96 | Hemiplegia (HP:0002301) | 2.21241951 |
| 97 | Progressive inability to walk (HP:0002505) | 2.18173453 |
| 98 | Chronic hepatic failure (HP:0100626) | 2.15807410 |
| 99 | Recurrent sinusitis (HP:0011108) | 2.15070066 |
| 100 | Cystic liver disease (HP:0006706) | 2.14579578 |
| 101 | Nephronophthisis (HP:0000090) | 2.14404363 |
| 102 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.14191222 |
| 103 | Anorexia (HP:0002039) | 2.14180706 |
| 104 | Cerebellar dysplasia (HP:0007033) | 2.12837959 |
| 105 | Hypochromic anemia (HP:0001931) | 2.10955067 |
| 106 | Gingivitis (HP:0000230) | 2.10506242 |
| 107 | Keratitis (HP:0000491) | 2.09726546 |
| 108 | Febrile seizures (HP:0002373) | 2.09588492 |
| 109 | Abnormality of the renal medulla (HP:0100957) | 2.08846709 |
| 110 | Epistaxis (HP:0000421) | 2.06771808 |
| 111 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06630731 |
| 112 | Autoimmune thrombocytopenia (HP:0001973) | 2.04282878 |
| 113 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.03703437 |
| 114 | Abnormality of the pleura (HP:0002103) | 2.03242906 |
| 115 | Increased corneal curvature (HP:0100692) | 2.02911231 |
| 116 | Keratoconus (HP:0000563) | 2.02911231 |
| 117 | Renal cortical cysts (HP:0000803) | 2.02590551 |
| 118 | Abnormality of B cell number (HP:0010975) | 2.01559935 |
| 119 | Congenital sensorineural hearing impairment (HP:0008527) | 1.99076718 |
| 120 | Abnormality of oral frenula (HP:0000190) | 1.96379051 |
| 121 | Frequent falls (HP:0002359) | 1.94606620 |
| 122 | Abnormal albumin level (HP:0012116) | 1.93805921 |
| 123 | Hypoalbuminemia (HP:0003073) | 1.93805921 |
| 124 | Glomerulopathy (HP:0100820) | 1.93715307 |
| 125 | Polydipsia (HP:0001959) | 1.93381765 |
| 126 | Abnormal drinking behavior (HP:0030082) | 1.93381765 |
| 127 | Recurrent otitis media (HP:0000403) | 1.93228041 |
| 128 | Absent/shortened dynein arms (HP:0200106) | 1.92759988 |
| 129 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.92759988 |
| 130 | Inability to walk (HP:0002540) | 1.91987990 |
| 131 | Protruding tongue (HP:0010808) | 1.91502084 |
| 132 | Constricted visual fields (HP:0001133) | 1.91319935 |
| 133 | Decreased circulating renin level (HP:0003351) | 1.91162716 |
| 134 | Polyneuropathy (HP:0001271) | 1.90433266 |
| 135 | Abnormality of the endocardium (HP:0004306) | 1.90231950 |
| 136 | Generalized hypopigmentation of hair (HP:0011358) | 1.89760464 |
| 137 | Bronchitis (HP:0012387) | 1.88071334 |
| 138 | Hypoplasia of the pons (HP:0012110) | 1.87907650 |
| 139 | Fair hair (HP:0002286) | 1.87896121 |
| 140 | Increased cerebral lipofuscin (HP:0011813) | 1.86491101 |
| 141 | Hematochezia (HP:0002573) | 1.85769002 |
| 142 | Decreased central vision (HP:0007663) | 1.85240625 |
| 143 | Facial diplegia (HP:0001349) | 1.85122651 |
| 144 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.83843493 |
| 145 | Abnormality of the pons (HP:0007361) | 1.82797757 |
| 146 | Prolonged bleeding time (HP:0003010) | 1.81543058 |
| 147 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.80816479 |
| 148 | Amyotrophic lateral sclerosis (HP:0007354) | 1.78905365 |
| 149 | Hypoplasia of the thymus (HP:0000778) | 1.78341175 |
| 150 | Verrucae (HP:0200043) | 1.78254270 |
| 151 | Papilloma (HP:0012740) | 1.78254270 |
| 152 | Hepatitis (HP:0012115) | 1.76852905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.10127116 |
| 2 | TXK | 6.30067390 |
| 3 | MAP4K1 | 4.92963336 |
| 4 | ITK | 3.50210119 |
| 5 | ZAP70 | 3.33029077 |
| 6 | JAK3 | 3.27177387 |
| 7 | ACVR1B | 3.15701374 |
| 8 | TYK2 | 2.57489652 |
| 9 | IRAK4 | 2.45253296 |
| 10 | STK10 | 2.37642212 |
| 11 | IKBKE | 2.29695880 |
| 12 | MAP3K14 | 2.29180202 |
| 13 | JAK1 | 2.28750570 |
| 14 | GRK6 | 2.12750150 |
| 15 | BMPR1B | 2.11029407 |
| 16 | FGFR4 | 2.08578552 |
| 17 | LCK | 2.05445858 |
| 18 | TESK2 | 2.00741195 |
| 19 | CSK | 1.98998135 |
| 20 | MST4 | 1.93814817 |
| 21 | TBK1 | 1.92882548 |
| 22 | BLK | 1.88411440 |
| 23 | TEC | 1.79992631 |
| 24 | BTK | 1.69500799 |
| 25 | MAP3K12 | 1.68747240 |
| 26 | CLK1 | 1.60294651 |
| 27 | MAP3K13 | 1.57090614 |
| 28 | PIK3CG | 1.51813483 |
| 29 | GRK1 | 1.45309793 |
| 30 | SYK | 1.41645657 |
| 31 | RIPK4 | 1.39485196 |
| 32 | NUAK1 | 1.39418914 |
| 33 | KDR | 1.38224816 |
| 34 | ZAK | 1.37336558 |
| 35 | FGFR3 | 1.36249430 |
| 36 | INSRR | 1.34525446 |
| 37 | CAMKK2 | 1.31232287 |
| 38 | KIT | 1.30448338 |
| 39 | NLK | 1.27429604 |
| 40 | PTK2B | 1.22599671 |
| 41 | MAP2K6 | 1.18920893 |
| 42 | MAPK13 | 1.18567878 |
| 43 | SRPK1 | 1.18395250 |
| 44 | ADRBK1 | 1.17664738 |
| 45 | HCK | 1.14723473 |
| 46 | LRRK2 | 1.13951091 |
| 47 | PRKD2 | 1.13672761 |
| 48 | IKBKB | 1.12972289 |
| 49 | TLK1 | 1.12388543 |
| 50 | PRKCQ | 1.10871682 |
| 51 | RPS6KA4 | 1.09868783 |
| 52 | AKT3 | 1.07493962 |
| 53 | TNK2 | 1.05587751 |
| 54 | IRAK3 | 1.04179121 |
| 55 | PIM1 | 1.00232473 |
| 56 | FES | 1.00162890 |
| 57 | LYN | 0.97967474 |
| 58 | GRK7 | 0.97182788 |
| 59 | MAP4K2 | 0.95564604 |
| 60 | NEK9 | 0.94870781 |
| 61 | WNK3 | 0.90940560 |
| 62 | OXSR1 | 0.90794722 |
| 63 | FLT3 | 0.89165283 |
| 64 | PRKCH | 0.88685033 |
| 65 | MAP3K10 | 0.84701167 |
| 66 | CSF1R | 0.82644173 |
| 67 | PINK1 | 0.82036513 |
| 68 | WNK4 | 0.81085308 |
| 69 | PIK3CA | 0.77235453 |
| 70 | TAOK3 | 0.77002386 |
| 71 | MARK3 | 0.73069425 |
| 72 | JAK2 | 0.71878333 |
| 73 | CDK3 | 0.71374667 |
| 74 | ADRBK2 | 0.71054224 |
| 75 | NME2 | 0.69288566 |
| 76 | MUSK | 0.68232533 |
| 77 | SIK2 | 0.67210252 |
| 78 | SGK2 | 0.66338251 |
| 79 | TGFBR2 | 0.63078763 |
| 80 | STK38 | 0.61801576 |
| 81 | HIPK2 | 0.60960089 |
| 82 | GRK5 | 0.60137308 |
| 83 | NTRK3 | 0.59688943 |
| 84 | CHUK | 0.59593523 |
| 85 | STK39 | 0.59112586 |
| 86 | PAK3 | 0.57737762 |
| 87 | STK11 | 0.57178509 |
| 88 | EEF2K | 0.56360783 |
| 89 | CAMKK1 | 0.54416654 |
| 90 | TRPM7 | 0.54281795 |
| 91 | MAP3K4 | 0.53350977 |
| 92 | BMPR2 | 0.52798369 |
| 93 | SIK3 | 0.51832891 |
| 94 | MAP3K8 | 0.50747410 |
| 95 | IRAK1 | 0.49494860 |
| 96 | TGFBR1 | 0.49105701 |
| 97 | RPS6KA6 | 0.48740702 |
| 98 | FYN | 0.47419320 |
| 99 | CDK4 | 0.46178096 |
| 100 | DAPK2 | 0.46089136 |
| 101 | MYLK | 0.45894487 |
| 102 | EPHB1 | 0.45608773 |
| 103 | TAOK1 | 0.43647951 |
| 104 | PDK1 | 0.42498161 |
| 105 | RPS6KL1 | 0.41817647 |
| 106 | RPS6KC1 | 0.41817647 |
| 107 | PRKCE | 0.41788108 |
| 108 | IGF1R | 0.40913316 |
| 109 | TYRO3 | 0.40451261 |
| 110 | MAP3K7 | 0.39866272 |
| 111 | INSR | 0.38700019 |
| 112 | STK24 | 0.37048770 |
| 113 | IRAK2 | 0.37040278 |
| 114 | TTN | 0.36947914 |
| 115 | ERBB2 | 0.34203259 |
| 116 | PRKAA2 | 0.34154659 |
| 117 | CAMK1 | 0.33503008 |
| 118 | NEK2 | 0.32113721 |
| 119 | MAPKAPK3 | 0.31977789 |
| 120 | OBSCN | 0.31006129 |
| 121 | ABL1 | 0.30371201 |
| 122 | SGK494 | 0.29089318 |
| 123 | SGK223 | 0.29089318 |
| 124 | MAP2K3 | 0.28844827 |
| 125 | MAPK11 | 0.28746208 |
| 126 | CSNK1D | 0.28707045 |
| 127 | MAPKAPK2 | 0.27965060 |
| 128 | PKN1 | 0.27902119 |
| 129 | TESK1 | 0.27610715 |
| 130 | BUB1 | 0.26343209 |
| 131 | MAPK4 | 0.26232298 |
| 132 | MELK | 0.26065573 |
| 133 | EPHA3 | 0.25935087 |
| 134 | PDGFRB | 0.25240715 |
| 135 | FGFR1 | 0.25194199 |
| 136 | STK4 | 0.25058061 |
| 137 | MARK2 | 0.25030382 |
| 138 | PRKCD | 0.24070238 |
| 139 | TSSK6 | 0.24025218 |
| 140 | CDK9 | 0.21960314 |
| 141 | DMPK | 0.21589511 |
| 142 | RAF1 | 0.21274432 |
| 143 | FGR | 0.19989452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 6.29305876 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.07090121 |
| 3 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.79278884 |
| 4 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 4.13779322 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.29515866 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.03583102 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.92185645 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.62294088 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.22830842 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15101063 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04095630 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.01858964 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01160721 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96169881 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.82775214 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.80139134 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.79990986 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.73911540 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62433250 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.61665625 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61471918 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59028172 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58855750 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.51005616 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.49855478 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.49422054 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46172793 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46156371 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36128293 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34217423 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32556147 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27175320 |
| 33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.20545455 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.19812203 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19319706 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.17455535 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16910215 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.16530324 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16116870 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.12101769 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.12015710 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11728578 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.10432509 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07630286 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.07004923 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 1.05893719 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03685313 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03110702 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00109936 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99827402 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98707364 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 0.97795099 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97754315 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.96599842 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96554906 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94749453 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94127003 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.93162545 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93124674 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93027549 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90551369 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.90148198 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88054157 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80691613 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79371615 |
| 66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79046849 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78484482 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76316634 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75700554 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75433322 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74515028 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74514614 |
| 73 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73303926 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72127561 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72111529 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.70853260 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70444845 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.69655189 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69627268 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.69450451 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69408258 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.69053460 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67541239 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65583882 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.62051848 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61798481 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60452110 |
| 88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60178354 |
| 89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59536632 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58959997 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.58869132 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57722668 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57352195 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56569424 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56494364 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56074763 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55196070 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52520347 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.52384033 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51230340 |
| 101 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51198519 |
| 102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51002667 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50423188 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50263695 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49871992 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49757839 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49486097 |
| 108 | DNA replication_Homo sapiens_hsa03030 | 0.48816280 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.48476425 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48462020 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47278874 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45093241 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43237619 |
| 114 | Asthma_Homo sapiens_hsa05310 | 0.42309101 |
| 115 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41880530 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.41441705 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41187224 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41035025 |
| 119 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40690999 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40305380 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40156649 |
| 122 | Insulin secretion_Homo sapiens_hsa04911 | 0.38709009 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36432809 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.34881083 |
| 125 | Spliceosome_Homo sapiens_hsa03040 | 0.32000684 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29171912 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.28274867 |
| 128 | Mismatch repair_Homo sapiens_hsa03430 | 0.27271134 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25704050 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25068896 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24724913 |
| 132 | Base excision repair_Homo sapiens_hsa03410 | 0.21974878 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21801481 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20407266 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16616580 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.15899729 |
| 137 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.15674048 |
| 138 | Focal adhesion_Homo sapiens_hsa04510 | 0.15198703 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.14948993 |
| 140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14104383 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13279368 |
| 142 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.12863007 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.10358083 |
| 144 | Pathways in cancer_Homo sapiens_hsa05200 | 0.09244589 |
| 145 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08792213 |
| 146 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.08040988 |
| 147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05780219 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.05700389 |
| 149 | Proteasome_Homo sapiens_hsa03050 | 0.05420370 |
| 150 | Prostate cancer_Homo sapiens_hsa05215 | 0.05275429 |
| 151 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.04478101 |
| 152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.01916820 |
| 153 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.01727868 |
| 154 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.00661106 |
| 155 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.00432809 |

